Elliott Vichinsky, MD
|School||UCSF School of Medicine|
|Address||401 Parnassus Ave.|
San Francisco CA 94143
|University of Wisconsin, Madison||B.S. ||1970||Biology|
|State University of New York Downstate||M.D.||1974||School of Medicine|
|Children's Orthopedic Hospital and Medical Center, Seattle, WA||Internship||1975||Pediatrics|
|Children's Orthopedic Hospital and Medical Center, Seattle, WA||Fellowship||1978||Pediatrics|
|University of Washington, Seattle, WA||Senior Research Fellow||1979||Dept of Pediatrics and Medicine|
|Sickle Cell Disease Association of America (SCDAA)||2013||Pioneer Award|
|Cooley's Anemia Foundation||2009||Distinguished Leadership as Chair of the Medical Advisory Board|
|Sickle Cell Disease Foundation of California||2007||Lifetime Achievement Award|
|Children's Hospital & Research Center Oakland||2005||Bronze Bambino Lifetime Achievement Award|
|Children's Miracle Network||1995||Miracle Maker Award|
|Alpha Omega Alpha Honor Society||1974||Alpha Omega Award|
|State University of New York Downstate||1974||Cum Laude|
|University of Wisconsin||1970||Cum Laude|
I am the Director of Hematology/Oncology at UCSF Benioff Children's Hospital Oakland, Adjunct Professor at University of California San Francisco, as well as the Director of the Northern California Sickle Cell and Thalassemia Centers. I am a board-certified pediatric hematologist/oncologist with a major interest in understanding and improving the care of patients with hemoglobinopathies. My career has focused on translational research in hemoglobinopathies to answer therapeutic questions in hematologic and iron overload disorders, including iron metabolism and its consequences in multiple diseases, alloimmunization, transfusion efficacy and risks in hematology.
Over 30 years ago, I established the hemoglobinopathy center at Children's Hospital Oakland to provide primary through tertiary care to pediatric and adult patients. I have been a federally-funded research investigator for over 30 years and national principal investigator for many successful trials -- including transfusion therapy and chelation therapy in hemoglobinopathies. I have been principal investigator or co-investigator on many of the key translational studies, including understanding the mechanism and treatment of neurologic injury in sickle cell disease; iron trafficking and iron overload in hemoglobinopathies, and new therapies to change the pathophysiology of sickle cell biology.
I have served as Editor-in-Chief of Pediatric Hematology and Oncology; Chairman of the Thalassemia Clinical Research Network, and Director of the Cooley’s Medical Board.
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.